GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock Position Decreased by Exencial Wealth Advisors LLC

Exencial Wealth Advisors LLC lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 24.6% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 188,931 shares of the company’s stock after selling 61,487 shares during the period. Exencial Wealth Advisors LLC’s holdings in GE HealthCare Technologies were worth $17,731,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Graypoint LLC boosted its stake in GE HealthCare Technologies by 6.3% during the 3rd quarter. Graypoint LLC now owns 2,768 shares of the company’s stock valued at $260,000 after purchasing an additional 164 shares during the period. Financial Enhancement Group LLC acquired a new position in GE HealthCare Technologies during the 3rd quarter valued at about $2,353,000. M&G PLC boosted its stake in GE HealthCare Technologies by 4.6% during the 3rd quarter. M&G PLC now owns 83,095 shares of the company’s stock valued at $7,811,000 after purchasing an additional 3,673 shares during the period. LGT Financial Advisors LLC boosted its stake in GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares during the period. Finally, Radnor Capital Management LLC boosted its stake in GE HealthCare Technologies by 4.5% during the 3rd quarter. Radnor Capital Management LLC now owns 8,838 shares of the company’s stock valued at $829,000 after purchasing an additional 383 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Wednesday, September 18th. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their price target for the stock from $84.00 to $74.00 in a research note on Thursday, September 26th. Wells Fargo & Company upped their price target on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. Finally, Stifel Nicolaus upped their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research note on Monday, September 30th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $94.36.

GE HealthCare Technologies Stock Down 1.6 %

GEHC stock opened at $86.78 on Thursday. GE HealthCare Technologies Inc. has a 52-week low of $66.39 and a 52-week high of $94.55. The company’s 50 day simple moving average is $88.80 and its 200-day simple moving average is $83.48. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The firm has a market capitalization of $39.65 billion, a P/E ratio of 23.84, a P/E/G ratio of 3.12 and a beta of 1.24.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The business had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. During the same quarter in the previous year, the business earned $0.99 earnings per share. The firm’s revenue was up .9% compared to the same quarter last year. As a group, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.29 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a $0.03 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.12 annualized dividend and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is presently 3.30%.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the company’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.27% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.